Revance Therapeutics — Post-IPO Debt
Revance Therapeutics raised $300.0M in a Post-IPO Debt round. View investors, financials, and press on Fsome.
Round Details
- Funded Company
- Revance Therapeutics
- Round Type
- Post-IPO Debt
- Amount Raised
- $300.0M
- Announced
- March 21, 2022
Canonical: https://fsome.com/funding/revance-therapeutics-post-ipo-debt-6125863 · For the full investor list, press references, and related rounds, please enable JavaScript.